Like InforMed Direct

closed 8/2/2010 via BNC Analysis

United Drug plc, acquired InforMed Direct

synopsis: United Drug Plc, an Ireland-based healthcare services provider, has acquired the entire share capital of InforMed Direct Plc, a UK-based healthcare communications and market research agency, for a consideration of GBP11.4 million in cash.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: InforMed Direct
InforMed offers healthcare communications at every stage of the product lifecycle – from development and consultancy to tactical delivery. Its market research and business analysis division delivers quant and qual research, as well as forecasting and market simulation models.
price ($mm)
$18
rev ($mm)
$16
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
closed 1/2/2018 via PR Newswire

ZS Associates, purchased BASES Pharmaceutical Forecasting from The Nielsen Company, Inc.

synopsis: ZS announced it has acquired the assets of BASES Pharmaceutical Forecasting from Nielsen. The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
buyer: ZS Associates
ZS Associates is a global management consulting firm specializing in sales and marketing strategy, operations and execution. Founded in 1983, ZS has grown into a firm of 500 professionals delivering expertise across much of the sales and marketing spectrum. "
seller: The Nielsen Company, Inc. (NLSN:$6,465.00)
The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/17/2012 via PR Newswire

Campbell Alliance Group, Inc., will purchase Promotional and Medical Audit Businesses from SDI Health LLC

synopsis: inVentiv Health, Inc. has entered into a definitive agreement to acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Campbell Alliance Group, Inc.
Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services to companies seeking to accelerate performance. "
seller parent: TPG Capital
seller: SDI Health LLC
SDI Health is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2011 via BNC Analysis

IMS Health Incorporated, acquired SDI Health LLC

synopsis: IMS Health has completed its acquisition of SDI, a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations. "
target parent: LLR Partners
target: SDI Health LLC
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
$340
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2010 via PR Newswire

Decision Resources, Inc., acquired BioTrends Research Group, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/7/2008 via PR Newswire

Quintiles Transnational Corp., will acquire Eidetics

synopsis: Quintiles Transnational Corp. announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the only fully integrated bio and pharmaceutical services provider offering clinical, commercial, consulting and capital solutions. Our 23,000 employees in more than 50 countries have helped develop or commercialize all of the top 30 best-selling drugs. "
target: Eidetics
Eidetics is being acquired by Quintiles. A market research and consulting company serving the world's leading pharmaceutical, biotechnology, and medical device companies. Headquartered in Boston, we have extensive international resources to address the global nature of today's marketing challenges.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via PR Newswire

Decision Resources, Inc., acquired Arlington Medical Resources Inc.

synopsis: Berkery Noyes, the leading independent investment bank serving the media, information and technology markets, announces that it represented Arlington Medical Resources, Inc. in its sale to Decision Resources, Inc., a portfolio company of Providence Equity Partners, Inc. Terms of the transaction were not disclosed.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Arlington Medical Resources Inc.
AMR is a privately held pharmaceutical market research firm headquartered in suburban Philadelphia. We have been serving the market research needs of the pharmaceutical & diagnostic imaging industries since 1988.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/22/2004 via PR Newswire

Ventiv Health, acquired HHI Clinical Research & Statistical Services, L.L.C.

synopsis: Ventiv Health, Inc. VTIV, a leading provider of late-stage clinical, sales, marketing and compliance services to pharmaceutical and biotech organizations, today announced that it has successfully completed the acquisition of HHI Clinical & Statistical Research Services, L.L.C.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: HHI Clinical Research & Statistical Services, L.L.C.
HHI Clinical Research & Statistical Services, L.L.C. is a focused clinical service provider managing statistical analysis and data management functions for pharmaceutical and biotechnology companies. HHI's services include data support, programming, statistical analysis and report writing. HHI has
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/16/2004 via PR Newswire

Thomson Scientific & Healthcare, acquired Newport Strategies, Inc.

synopsis: The Thomson Corporation announced that it has acquired Newport Strategies, Inc., a leading provider of competitive intelligence for the pharmaceutical industry. Newport Strategies will become part of the scientific business within the Thomson Scientific and Healthcare market group.
buyer parent: The Thomson Corporation
buyer: Thomson Scientific & Healthcare (:$964.58)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
target: Newport Strategies, Inc.
Newport develops and markets cutting-edge systems that deliver the earliest and most reliable source of global intelligence on competition for launched pharmaceutical products. Innovator, generic and specialty pharmaceutical companies worldwide use Newport's systems and expert confidential consulti
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/26/2005 via PR Newswire

Greenfield Online, Inc., acquired Rapidata.net, Inc.

synopsis: Greenfield Online, Inc SRVY, a leading provider of Internet survey solutions to marketing research and consulting companies, today announced it has completed the acquisition of Rapidata.net, Inc., a privately-held North Carolina corporation, for $5.5 million in cash, subject to certain post closing adjustments.
buyer: Greenfield Online, Inc. (SRVY:$0.00)
Greenfield Online, Inc. is a global interactive media and services company that collects consumer attitudes about products and services, enabling consumers to reach informed purchasing decisions about the products and services they want to buy; and helping companies better understand their customer."
target: Rapidata.net, Inc.
Founded fifteen years ago by research pharmacist and professor David P. Lipson, R.PH., Ph.D., Rapidata.net connects pharmaceutical market researchers to healthcare providers and their patients. This connection allows pharmaceutical market researchers to learn more about the prescription medications
price ($mm)
$5.50
rev ($mm)
$2
EBITDA ($mm)
EV / rev
2.6x
EV / EBITDA
closed 9/25/2020 via BusinessWire

W2O Group, acquired Elysia Group

synopsis: W2O, the leading independent provider of analytics-driven, technology-enabled marketing and communications solutions to the healthcare sector, announced it has acquired Elysia Group, a health economic and outcomes research (HEOR) consulting firm operating in the United States and Asia Pacific.
buyer parent: New Mountain Capital, LLC
buyer: W2O Group
W2O is an independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. "
target: Elysia Group
Elysia Group is a health economic and outcomes research consulting firm. Elysia provides pharmaceutical and medical device clients with innovative modeling approaches to health economic strategy and evidence development using data and analytics and real-world evidence.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/25/2012 via PR Newswire

McCann Health, acquired Double Helix

synopsis: McCann Health announced the acquisition of Double Helix. Double Helix is a leading, global provider of Market Research and Market Access services to the pharmaceutical and medical device industries. Dr. Wayne Phillips, who founded and runs Double Helix, will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.
buyer parent: Interpublic Group of Companies, Inc.
buyer: McCann Health
Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. "
target: Double Helix
Double Helix is an independent healthcare consultancy with headquarters in London and offices in the US and Singapore. Established in 1995, they have been providing pharmaceutical, biotech and medical device clients of all sizes with the knowledge to evolve their brands and businesses.
price ($mm)
$55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/14/2009 via BusinessWire

Majestic Research, LLC, acquired Rood Research, Inc.

synopsis: Majestic Research, a global, independent equity research company and a pioneer in data driven analysis, announced its acquisition of New York-based Rood Research – a leading provider of healthcare market research.
buyer: Majestic Research, LLC
Since its inception in 2002, Majestic Research has revolutionized the financial research business with our innovative proprietary methods and tools for accessing real-time data. "
target: Rood Research, Inc.
In the past 15 years, Rood Research has become a leader in providing healthcare research to some of the top pharmaceutical and biotech companies in the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2008 via BusinessWire

Surveillance Data, Inc., acquired Verispan, LLC

synopsis: SDI, the leader in innovative healthcare analytics, has acquired Verispan, a top provider of healthcare information and services. The acquisition creates the healthcare industry’s most comprehensive de-identified longitudinal database.
buyer parent: LLR Partners
buyer: Surveillance Data, Inc.
SDI provides a wide range of healthcare data and market research to pharmaceutical, consumer products, and healthcare-related companies. Since 1981, SDI's mission has been to provide healthcare data products with high business relevance as well as the means and know-how to put this data into action."
target: Verispan, LLC
Verispan provides a broad array of information products and services to virtually all of the top 50 pharmaceutical companies and the healthcare industry in general, including sales targeting and compensation products; market research audits; healthcare profiles; and direct mail, among many others.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/14/2020 via PR Newswire

Medical Knowledge Group LLC, acquired Magnolia Innovation, LLC

synopsis: Medical Knowledge Group, LLC, an analytics-driven and technology-enabled multichannel health care marketing and communications conglomerate whose operating companies serve the biopharmaceutical industry, has acquired Magnolia Innovation, a premier market research and strategy consulting firm.
buyer parent: Court Square Capital Partners
buyer: Medical Knowledge Group LLC
Medical Knowledge Group, through its operating companies, provides specialized medical communications services, proprietary analytic solutions, and market research services to the biopharmaceutical industry. "
target: Magnolia Innovation, LLC
Magnolia Innovation is a market research and consulting firm focusing exclusively in the life sciences. Magnolia has decades of combined experience building, launching, and redefining biopharmaceutical brands to drive innovation through insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/16/2018 via Company Press Release

Vestar Capital Partners, will acquire Information Resources, Inc.

synopsis: Vestar Capital Partners, a private equity firm, will lead a new investment in Information Resources, Inc., a leading provider of big data, predictive analytics and forward-looking insights. Jeffrey Ansell, a Vestar Senior Advisor, will serve as Chairman of IRI. New Mountain and other existing investors are retaining a meaningful investment in IRI.
buyer: Vestar Capital Partners
Vestar Capital Partners (VCP) is a private equity firm specializing in management buyouts and growth capital investments. VCP collaborates with management teams and private owners to build long- term enterprise value, with a focus on Consumer, Healthcare, and Business Services & Industrial Products."
target parent: New Mountain Capital, LLC
target: Information Resources, Inc.
Information Resources, Inc. is a leading provider of big data, predictive analytics and forward-looking insights that help CPG companies, OTC health care organizations, retailers, financial services and media companies grow their businesses.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2018 via Company Press Release

BioInformatics Inc., acquired Kalorama Information

synopsis: BioInformatics Inc., the premier research and advisory company serving the life science industry, has acquired Kalorama Information from MarketResearch. Kalorama Information is a leading publisher of market research in healthcare areas, including in vitro diagnostics, imaging, biotechnology, healthcare, medical devices, and pharmaceuticals.
buyer: BioInformatics Inc.
BioInformatics Inc. is the leading research and advisory firm serving the life science, diagnostic and analytical instrument industries. Their expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing and validating corporate acquisitions. "
target parent: MarketResearch.com, Inc.
target: Kalorama Information
Kalorama Information is a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), imaging, biotechnology, healthcare, medical devices, and pharmaceuticals. Kalorama only publishes in healthcare.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/6/2017 via Company Press Release

The Access Group, acquired Health Strategies Group

synopsis: Water Street Healthcare Partners, through its subsidiary, The Access Group, has acquired Health Strategies Group. Health Strategies Group is the leader in market access intelligence and customized research for pharmaceutical and biotech professionals. It dissects trends and identifies opportunities to help companies optimize their product access.
buyer parent: Water Street Healthcare Partners
buyer: The Access Group
The Access Group offers a breadth of services to clients, from traditional “block-and-tackle” launch execution tactics to in-depth market assessments. The company is dedicated to complete product life cycle management, creating brand solutions that drive demand across multiple stakeholder channels. "
target: Health Strategies Group
Health Strategies Group offers a dedicated team of research leaders committed to dissecting the trends, identifying customer needs, and pinpointing the barriers and opportunities for biopharma within the evolving health care environment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2010 via BNC Analysis

United Drug plc, acquired InforMed Direct

synopsis: United Drug Plc, an Ireland-based healthcare services provider, has acquired the entire share capital of InforMed Direct Plc, a UK-based healthcare communications and market research agency, for a consideration of GBP11.4 million in cash.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: InforMed Direct
InforMed offers healthcare communications at every stage of the product lifecycle – from development and consultancy to tactical delivery. Its market research and business analysis division delivers quant and qual research, as well as forecasting and market simulation models.
price ($mm)
$18
rev ($mm)
$16
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
closed 11/26/2019 via Company Press Release

UDG Healthcare plc, acquired Canale Communications

synopsis: UDG Healthcare, an Ireland-based global leader in healthcare advisory, communications, commercial, clinical and packaging services, has acquired Canale Communications, a strategic communications and creative firm exclusively serving the life science and healthcare industries.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
Headquartered in Ireland, UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Canale Communications
Canale Communications is a strategic communications and creative firm exclusively serving the life science and healthcare industries. It has worked with more than 300 biotech, health tech, and pharmaceutical companies at virtually every stage of development.
price ($mm)
$20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via Company Press Release

UDG Healthcare plc, acquired Putnam Associates

synopsis: UDG Healthcare plc, a leading international healthcare services provider, announces the acquisition of Putnam Associates, a company that provides strategic advice based on sophisticated and robust analytics to biopharmaceutical, diagnostics, and medical device clients.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Putnam Associates
Putnam Associates serves global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world class strategic advice based on sophisticated, robust analytics.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/4/2018 via Company Press Release

Ashfield Commercial & Medical Services, acquired Create NYC

synopsis: UDG Healthcare plc, a leading international healthcare services provider, is pleased to announce the acquisition of Create NYC, a New York-based disruptive creative communications agency. The business will become part of UDG's Ashfield Communications, a global leader in commercialisation services for the pharmaceutical and healthcare industry.
buyer parent: UDG Healthcare plc
buyer: Ashfield Commercial & Medical Services
Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry. They provide field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services. "
target: Create NYC
Create NYC is an innovative New York-based healthcare creative communications agency, offering the tactical execution of sales and marketing materials for its international pharmaceutical clients.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/4/2018 via Company Press Release

Ashfield Commercial & Medical Services, acquired SmartAnalyst, Inc.

synopsis: UDG Healthcare plc, a leading international healthcare services provider, is pleased to announce the acquisition of SmartAnalyst, a New York-based strategic commercialisation consulting and analytics business. The business will become part of Ashfield Communications.
buyer parent: UDG Healthcare plc
buyer: Ashfield Commercial & Medical Services
Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry. They provide field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services. "
target: SmartAnalyst, Inc.
SmartAnalyst is a US-based strategic consulting and analytics business focused on the pharmaceutical and biotech sector. SmartAnalyst provides strategic consulting services to pharmaceutical and biotech companies to support disease, asset, and portfolio level decisions.
price ($mm)[EV]
$18 [$12]
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/20/2017 via BNC Analysis

UDG Healthcare plc, acquired MicroMass Communications, Inc.

synopsis: UDG Healthcare, an international healthcare services provider, announced the acquisition of MicroMass Communications, a U.S.-based healthcare communications agency specializing in behavioural change.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare plc is a leading international partner of choice delivering clinical, commercial, communication and packaging services to the healthcare industry, employing 8,000 with operations in 23 countries and delivering services in over 50 countries. "
target parent: Periscope Equity
target: MicroMass Communications, Inc.
MicroMass Communications is a healthcare marketing agency specializing in digital, relationship marketing, and non-personal promotion. Their unique expertise in human health behavior allows them to create highly effective solutions for patients and health care providers.
price ($mm)
$64
rev ($mm)
$23
EBITDA ($mm)
EV / rev
3.3x
EV / EBITDA
closed 5/19/2016 via Company Press Release

Ashfield Commercial & Medical Services, acquired Pegasus Public Relations Ltd

synopsis: Pegasus, one of the most successful integrated healthcare communications consultancies in the UK, announced it has been acquired by UDG Healthcare plc, an international provider of outsourced healthcare services. Pegasus joins Ashfield Healthcare Communications, which is part of UDG Healthcare’s Ashfield Commercial and Medical Services Division.
buyer parent: UDG Healthcare plc
buyer: Ashfield Commercial & Medical Services
Ashfield is a global leader in providing outsourced healthcare services to pharmaceutical, device and biotech companies. Ashfield provides contract sales teams, customer service reps, remote detailing, nurse educators, medical information, healthcare communications, and other services. "
target: Pegasus Public Relations Ltd
Pegasus specialises in helping private and public sector organisations communicate healthy messages through integrated communications programmes. Pegasus has an award-winning track record of creating and implementing campaigns that inspire behavior change.
price ($mm)
$15
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/27/2014 via BNC Analysis

UDG Healthcare plc, acquired KnowledgePoint360

synopsis: UDG Healthcare plc, a leading international provider of healthcare services, announced that it has agreed to acquire the healthcare communications business of KnowledgePoint360. The deal, agreed at a total cash consideration of $144 million. KnowledgPoint360 provides a broad range of medical communications services.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare plc, together with its subsidiaries provides supply chain, packaging, medical, regulatory, and sales and marketing services to healthcare manufacturers and pharmacies operating in the Republic of Ireland, the United Kingdom, North America, and continental Europe. "
target parent: ABRY Partners, LLC
target: KnowledgePoint360
KnowledgPoint360 provides a broad range of medical communications services, including medical education, publication support, live educational meetings, scientific content development, exhibit design, digital solutions, training, workflow and compliance solutions.
price ($mm)
$144
rev ($mm)
$106
EBITDA ($mm)
$20
EV / rev
1.4x
EV / EBITDA
7.2x
announced 8/28/2012 via BNC Analysis

United Drug plc, will acquire Drug Safety Alliance, Inc.

synopsis: Irish healthcare services provider United Drug plc announced an agreement to acquire North Carolina based Drug Safety Alliance Inc. DSA is a global leader in safety and risk management services supporting pharmaceutical, biotech, medical device, consumer health and animal health organizations.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: Drug Safety Alliance, Inc.
Drug Safety Alliance, Inc. is a provider of clinical trial and post-marketing drug safety and pharmacovigilance solutions to the pharmaceutical and biotech industries. DSA manages services including case management, regulatory consulting, quality management, and a secure, validated safety database.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/28/2012 via BNC Analysis

United Drug plc, will acquire Synopia RX, LLC

synopsis: Irish healthcare services provider United Drug plc, announced an agreement to acquire Synopia RX LLC. SynopiaRx consults with BioTech and Pharmaceutical companies as well as investment organizations to deliver market intelligence, strategies and account management.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: Synopia RX, LLC
SynopiaRx engages with companies in the BioTech and Pharmaceutical industry to optimize their commercialization of medicines in the managed care marketplace.
price ($mm)
$3.20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/26/2012 via BNC Analysis

United Drug plc, acquired Watermeadow

synopsis: United Drug plc (UD) announced that it has acquired the entire issued share capital of Watermeadow Medical Ltd and Watermeadow Medical Consulting Inc for a total consideration of up to £13m. Watermeadow is a healthcare communications and consultancy agency headquartered in the UK with offices also in the US.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: Watermeadow
Watermeadow is a healthcare communications and consultancy agency headquartered in the UK with offices also in the US. It provides services to global pharmaceutical companies, including medical writing and preparation of promotional and educational materials typically for products pre-launch.
price ($mm)
$9.35
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2010 via Company Press Release

United Drug plc, acquired World Events Group, Ltd.

synopsis: United Drug, plc has acquired WorldEvents® Group, the global group of event management companies headed by WorldEvents® Group Limited. WorldEvents® is one of the UK’s top five event management businesses, specialising in the healthcare/pharmaceutical sector.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: World Events Group, Ltd.
WorldEvents® is an international event agency. WorldEvents® is ranked in the top ten event management agencies in Europe and has won numerous industry awards for the work it has conducted for its clients.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2010 via BNC Analysis

United Drug plc, acquired InforMed Direct

synopsis: United Drug Plc, an Ireland-based healthcare services provider, has acquired the entire share capital of InforMed Direct Plc, a UK-based healthcare communications and market research agency, for a consideration of GBP11.4 million in cash.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: InforMed Direct
InforMed offers healthcare communications at every stage of the product lifecycle – from development and consultancy to tactical delivery. Its market research and business analysis division delivers quant and qual research, as well as forecasting and market simulation models.
price ($mm)
$18
rev ($mm)
$16
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
closed 7/29/2015 via PE Hub

Tailwind Capital Partners, acquired National HME

synopsis: Tailwind Capital, a leading middle market private equity firm investing in growth-oriented companies in healthcare, business and communications services, announced the acquisition of National HME, Inc. (“NHME”). NHME is the largest provider of outsourced medical equipment management solutions to the hospice market.
buyer: Tailwind Capital Partners
Tailwind Capital Partners is an independent private equity firm focused on investments in healthcare, media/communications and business services companies. "
target: National HME
National HME, Inc. ("NHME") is the largest provider of outsourced medical equipment management solutions to the hospice market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/2/2004 via BusinessWire

McKesson Corporation, acquired Moore Medical Corporation

synopsis: McKesson Corporation (NYSE:MCK), the world's leading healthcare services company and the largest distributor of medical surgical supplies and pharmaceuticals to the alternate site marketplace, today announced that it has completed the acquisition of Moore Medical Corporation (AMEX:MMD) of New Britain, Conn.
buyer: McKesson Corporation (MCK:$214,319.00)
McKesson Corporation, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. "
target: Moore Medical Corporation
Moore Medical Corp. is an Internet-enabled multi-channel marketer and distributor of medical, surgical and pharmaceutical products to over 100,000 healthcare practices and facilities in non-hospital settings nationwide, including physicians, emergency medical technicians, schools, correctional inst
price ($mm)
$43
rev ($mm)
$143
EBITDA ($mm)
$2
EV / rev
0.3x
EV / EBITDA
20.2x
closed 1/20/2016 via BusinessWire

ASP Global, acquired InHome Medical Solutions

synopsis: ASP Global, an industry leader in global sourcing of hospital medical supplies, has acquired Jacksonville, FL based InHome Medical Solutions, a leading wholesale medical products distribution company serving physicians, home health and hospice providers. InHome's technology platform enables clinicians to easily order and track supplies online.
buyer: ASP Global
ASP Global is a leading global sourcing agent/wholesaler of medical supplies with a proven track record. Their long-standing relationships with 120+ factories enable them to deliver high quality products at factory pricing directly to their clients. "
target: InHome Medical Solutions
InHome Medical Solutions is a leading wholesale medical products distribution company serving physicians, home health and hospice providers. InHome delivers a comprehensive range of diabetic, respiratory, urological, incontinence, wound care, ostomy, and home medical equipment products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/10/2019 via PR Newswire

PNC Riverarch Capital, acquired Safco Dental Supply

synopsis: PNC Riverarch Capital, a middle-market private equity firm which invests in privately held companies, has acquired Safco Dental Supply, an online distributor of dental supplies to independent dental practitioners.
buyer parent: The PNC Financial Services Group
buyer: PNC Riverarch Capital
PNC Riverarch Capital is a middle-market private equity firm that invests in companies headquartered throughout North America. They work closely with their portfolio company teams to maximize their growth potential while preserving their culture and legacy. "
target: Safco Dental Supply
Safco Dental Supply is an online distributor of dental supplies to independent dental practitioners. They are known for offering top quality products at prices significantly lower than other dental supply dealers.
price ($mm)
$175
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like InforMed Direct


read more

InforMed Direct

The Nielsen Company, Inc.

Medical Collective Intelligence Co. Ltd.

PharmARC Analytic Solutions Pvt. Ltd.

SDI Health LLC

SDI Health LLC

BioTrends Research Group, Inc.

Eidetics

Arlington Medical Resources Inc.

HHI Clinical Research & Statistical Services, L.L.C.

Newport Strategies, Inc.

Rapidata.net, Inc.

Elysia Group

Double Helix

Rood Research, Inc.

Verispan, LLC

Magnolia Innovation, LLC

Information Resources, Inc.

Kalorama Information

Health Strategies Group

read more

InforMed Direct

read more

Canale Communications

Putnam Associates

Create NYC

SmartAnalyst, Inc.

MicroMass Communications, Inc.

Pegasus Public Relations Ltd

KnowledgePoint360

Drug Safety Alliance, Inc.

Synopia RX, LLC

Watermeadow

World Events Group, Ltd.

InforMed Direct

read more

National HME

Moore Medical Corporation

InHome Medical Solutions

Safco Dental Supply

TGaS Advisors, LLC

Geography
Matching Companies
Ticker: MCK
 
 
 
 
 
 
 
 
McKesson Corporation
McKesson Corporation
McKesson Corporation is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care.
year
2019
rev ($mm)
$214,319.00
EBITDA ($mm)
$4,229.00
EBIT ($mm)
$3,280.00
Net Income ($mm)
$34.00
Employees
70000
  • drill down
  • watch
Ticker: HSIC
 
 
 
 
 
 
 
 
Henry Schein, Inc.
Henry Schein, Inc.
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites.
year
2019
rev ($mm)
$13,288.81
EBITDA ($mm)
$1,117.53
EBIT ($mm)
$905.38
Net Income ($mm)
$505.45
Employees
19000
  • drill down
  • watch
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,298.52
EBITDA ($mm)
$178.30
EBIT ($mm)
$122.78
Net Income ($mm)
$57.45
Employees
7790
  • drill down
  • watch
Ticker: PDCO
 
 
 
 
 
 
 
 
Patterson Companies, Inc.
Patterson Companies, Inc.
Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets. As Patterson's largest business, Patterson Dental provides a virtually complete range of consumable dental products, equipment and software.
year
2012
rev ($mm)
$3,535.66
EBITDA ($mm)
$400.22
EBIT ($mm)
$358.01
Net Income ($mm)
$212.82
Employees
7059
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch